Despite the impact of COVID-19, the global Hepatitis B Diagnostic Tests Market grew at a healthy year-on-year (YoY) rate, reaching a valuation of approximately US$ 872.5 Million in 2022. With the global prevalence of hepatitis B increasing, the overall market is expected to grow at a 6.4% CAGR between 2022 and 2028, surpassing a valuation of US$ 1.26 Billion by the end of 2028.
Request for Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1332
High Prevalence of Hepatitis B in the APEJ Region Boosting Global Market Revenue Growth
The prevalence of hepatitis B is highest in the APEJ region and the disease burden caused by chronic cases of hepatitis B is enormous. APEJ region has more number of chronic hepatitis B patients than any other region in the world and is thus a potential market for hepatitis B test kit manufacturers. As per the data provided by WHO, China accounts for one-third of all chronic hepatitis B infections. In addition, 6.2% of the adult population in the Western Pacific region is infected with hepatitis B. In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country. As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3%-4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.
What Is Driving The Demand For Hepatitis B Diagnostic Tests In The US?
According to FMI, the hepatitis B diagnostic tests market in the United States will grow at a steady CAGR of 4.3% between 2022 and 2028. The country’s growth is attributed to rising health awareness, a well-established healthcare sector, the presence of key players, and the increasing prevalence of hepatitis B.
Diagnostic screening for hepatitis B has increased dramatically in the United States over the years. Rising health awareness and the involvement of the government and other healthcare organisations is boosting the country’s hepatitis B diagnostic tests market.
According to the US Department of Health and Human Services, approximately 850,000 people in the United States have hepatitis B. However, the true figure could be as high as 2.2 million or as low as 730,000.
The vast majority of people infected with hepatitis B are unaware that they are infected. Approximately 67% of people in the United States who have hepatitis B do not know they have the virus. As a result, early detection is critical to preventing the spread of the disease and lowering the mortality rate.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-1332
Global Hepatitis B Diagnostic Tests Market: Segmentation and Forecast
The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.
- On the basis of product type, the enzyme immunoassay kits segment was estimated to be valued at nearly US$ 590 Million in the year 2022 and is likely to reach a valuation of nearly US$ 1,100 Million in 2028, accounting for a CAGR of 6.2% during the assessment period 2022 to 2028.
- On the basis of end user, the hospitals segment was estimated to be valued at nearly US$ 250 Million in 2022 and is estimated to reach a valuation of nearly US$ 460 Million in 2028, registering a CAGR of 6.1% during the period of assessment.
- On the basis of region, the APEJ hepatitis B diagnostic tests market was estimated to be valued at nearly US$ 200 Million in 2022 and is likely to reach a valuation of nearly US$ 380 Million in 2028, accounting for a CAGR of 7.2% during the period of forecast.
Global Hepatitis B Diagnostic Tests Market: Competitive Landscape
This report features some of the important players functioning in the global hepatitis B diagnostic tests market such as bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1332
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs